Welcome to our dedicated page for Cactus Acquisition 1 SEC filings (Ticker: CCTSW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Cactus Acquisition Corp. 1 Limited (warrants trading under the symbol CCTSW) provides access to the company’s regulatory disclosures as a blank check company. Cactus Acquisition Corp. 1 Limited states that it was formed to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, with a focus on Israel-related technology-based healthcare companies.
Among the key documents available are annual reports on Form 10‑K. The company announced that it filed its Form 10‑K for the year ended December 31, 2021 with the Securities and Exchange Commission, and this filing outlines its structure as a SPAC, risk factors, and other required disclosures. Current reports on Form 8‑K are also important, as they describe material events such as changes in directors or officers and other significant developments.
One Form 8‑K excerpt notes the resignation of an independent director, specifying that the resignation was for personal reasons and not due to any disagreement with the company on matters related to operations, accounting principles, financial statement disclosure, or internal controls. Such filings help readers understand corporate governance and oversight at Cactus Acquisition Corp. 1 Limited.
On this page, users can review filings that reference the company’s ordinary shares and redeemable warrants, including details that each warrant is exercisable for one class ordinary share at a stated exercise price. Real-time updates from EDGAR, combined with AI-powered summaries, can help interpret lengthy documents like 10‑K and 8‑K reports, highlight key terms of the warrants associated with CCTSW, and clarify how board and governance changes are disclosed.
Cactus Acquisition Corp. 1 Limited Warrant (CCTSW) is asking shareholders to approve two proposals at an upcoming meeting. Proposal No. 1 seeks a special-resolution amendment to the company’s amended and restated memorandum and articles of association to extend the deadline to complete an initial business combination from November 2, 2025 to November 2, 2026, while allowing the board the discretion to wind up operations earlier. Proposal No. 2 is an ordinary-resolution request to permit adjournment of the meeting if further solicitation of proxies is needed for Proposal No. 1. The board recommends a vote FOR both proposals. The proxy material discloses security ownership: Cactus Healthcare Management LP holds 632,500 shares (16.11%), and several named individuals were assigned founder shares in specific amounts by the sponsor.
Kepos Capital LP and Mark Carhart report beneficial ownership of 200,000 Class A ordinary shares of Cactus Acquisition Corp. 1 Ltd, representing 5.1% of the outstanding Class A shares used in the filing calculation. The shares are held by funds managed by Kepos and are reported as held in the ordinary course of business; the filing states they were not acquired to change or influence control. The disclosure shows shared voting and dispositive power of 200,000 shares and identifies Kepos Special Opportunities Master Fund L.P. as holding more than 5% economic interest.
Cactus Acquisition Corp. 1 Limited is a blank check company formed to complete an initial business combination. As of March 31, 2025, the unaudited condensed balance sheet shows $21 (in thousands) of cash, $9,075 (in thousands) held in the trust account, and a total capital deficiency of $(2,242) (in thousands). For the three months ended March 31, 2025 the company reported a net loss of $(78) (in thousands) and interest income of $95 (in thousands) on trust investments.
The company has a signed Business Combination Agreement with Tembo e-LV B.V. under which Tembo equity holders would receive $838 million in newly issued shares valued at $10.00 per share; closing remains subject to regulatory approvals, audited financials, shareholder approval and SEC review of a Form F-4. Trading was suspended on Nasdaq and the company commenced trading on the OTC market under the symbol CCTSF. The company obtained a third extension of its combination deadline to November 2, 2025.
The filing discloses substantial doubt about the company’s ability to continue as a going concern, related-party and third-party promissory notes (including a $600,000 note with Energi with a balance of $646,000 as of March 31, 2025 and a sponsor loan balance of $780,000), and a material weakness in internal control over accounting for founder share assignments and insufficient finance personnel. A subsequent unsecured promissory note of $200,000 was issued on July 17, 2025.